Literature DB >> 23464816

Allergies in Germany -- prevalence and perception by the public.

Matthias Augustin1, Nadine Franzke, Florian C Beikert, Rudolf Stadler, Michael Reusch, Jochen Schmitt, Ines Schäfer.   

Abstract

BACKGROUND: During the recent decades allergies have become more frequent all over the world. However, it is unclear how important the topic of allergies is for the general German population and how appropriately patients with allergies are treated. PATIENTS AND METHODS: A telephone survey was performed on a representative random sample of n = 1,004 adults in Germany. The survey was performed by the Forsa Institute for Social Research and Statistical Analysis, Berlin, Germany, in the period from 31 January to 2 February 2012.
RESULTS: Of the interviewees 52% responded that the topic of allergies concerned them; in 33% actually an allergy had been diagnosed by a physician. The proportion of allergies in the population correlated with the level of school education and was higher among people with a higher educational status. No differences in allergy rates were found between Eastern and Western Germany. Among allergic persons, 53% reported to be burdened by their allergy, 48% suffered from impaired performance because of their allergic symptoms. Among people suffering from pollen allergy, only 28% received sublingual immune therapy, with which 70% were satisfied. While 58% practiced self-medication, only 21% of the allergic persons were treated with anti-allergic drugs during their allergy flares.
CONCLUSIONS: Allergic diseases are a common, often burdensome problem in the German population, but nevertheless the medical treatment of people affected is still insufficient. The proportion of patients receiving sublingual immune therapy as causal treatment is comparatively low. Active steps are needed to improve the utilization behavior of patients, e. g. to take advice of an allergy specialist.
© The Authors • Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23464816     DOI: 10.1111/j.1610-0387.2012.08049.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  4 in total

1.  Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy.

Authors:  Anna Langenbruch; Eike Wüstenberg; Hendrik Wolf; Matthias Augustin
Journal:  J Asthma Allergy       Date:  2022-05-11

2.  [What motivates patients with atopic diseases to search the internet-a focus group study on expectations and demands].

Authors:  K Drixler; E Luntz; R Wiedemann; J Lander; I Schäfer; J Schmitt; M-L Dierks; E M Bitzer
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

3.  Urban vs rural - Prevalence of self-reported allergies in various occupational and regional settings.

Authors:  Linda Tizek; Elisa Redlinger; Johannes Ring; Kilian Eyerich; Tilo Biedermann; Alexander Zink
Journal:  World Allergy Organ J       Date:  2022-01-27       Impact factor: 4.084

4.  State of the art in AIT: The patients' perspective.

Authors:  Sabine Jossé; Kymble Spriggs
Journal:  Allergol Select       Date:  2022-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.